RedHill Biopharma (RDHL) Non-cash Items (2012 - 2022)

RedHill Biopharma (RDHL) has 11 years of Non-cash Items data on file, last reported at -$2.9 million in Q4 2022.

• On a quarterly basis, Non-cash Items fell 121.36% year-over-year to -$2.9 million in Q4 2022; TTM through Dec 2022 was $28.6 million, a 15.55% decrease from a year earlier, with the FY2025 full-year figure at -$7.3 million, down 129.96% from the prior year.
• Non-cash Items for Q4 2022 stood at -$2.9 million, down from $29.3 million in the prior quarter.
• Over the last five years, Non-cash Items for RDHL reached as high as $29.3 million in Q3 2022 and fell as low as -$5.4 million in Q2 2022.
• Historically, Non-cash Items has averaged $4.6 million across 5 years, with a median of $3.4 million in 2018.
• Across the five-year window, Non-cash Items surged 530.63% in 2020 and tumbled 161.12% in 2022, its largest moves.
• Year by year, Non-cash Items stood at -$1.5 million in 2018, then soared by 176.34% to $1.2 million in 2019, then soared by 438.96% to $6.3 million in 2020, then jumped by 118.36% to $13.7 million in 2021, then plunged by 121.36% to -$2.9 million in 2022.
• Per Business Quant data, the three most recent Non-cash Items figures were -$2.9 million in Q4 2022, $29.3 million in Q3 2022, and -$5.4 million in Q2 2022.